Pipeline
Our lead medical device is our CeraShield Endotracheal Tube which FDA has designated as a “breakthrough device” and is approved for routine clinical use in Canada, Colombia, Brazil and other ex US countries. We expect FDA approval in 2024. The CeraShield ETT is designed to prevent Ventilator Associated Pneumonia (VAP) which is most common, deadly and costly HAI among ICU patients. The estimated worldwide costs associated with treating VAP exceeds Ten Billion Dollars annually.
Our platform technology allows us to revolutionize the safety of most indwelling medical devices and implants. By applying our innovative CeraShield coating to these devices, we aim to prevent Hospital-Acquired Infections (HAIs), thereby reducing the reliance on antibiotics and combating Antimicrobial Resistance (AMR).
Pipeline
Our lead medical device is our CeraShield Endotracheal Tube which FDA has designated as a “breakthrough device” and is approved for routine clinical use in Canada, Colombia, Brazil and other ex US countries. We expect FDA approval in 2024. The CeraShield ETT is designed to prevent Ventilator Associated Pneumonia (VAP) which is most common, deadly and
costly HAI among ICU patients. The estimated worldwide costs associated with
treating VAP exceeds Ten Billion Dollars annually.
Our platform technology allows us to revolutionize the safety of most indwelling medical devices and implants. By applying our innovative CeraShield coating to these devices, we aim to prevent Hospital-Acquired Infections (HAIs), thereby reducing the reliance on antibiotics and combating Antimicrobial Resistance (AMR).
Device | Designation | Indication | Research | Pre-clinical | Clinical | Commercialization | Partnership |
Biofilm-preventing | Medical device, indwelling | Prevention of VAP / VARI |  |  |  |  |  |
Antimicrobial absorbable Pacemaker envelope | Medical device, implant | Prevention of CIED infections |  |  |  JDA in discussion | ||
Coated pedicle screw | Medical device, implant | Prevention of implant-associated orthopedic infections |  |  |  JDA in discussion | ||
Biofilm-preventing hemodialysis catheter | Medical device, indwelling | Prevention of Hemodialysis Catheter-Related Infections |  |  |  JDA in discussion | ||
Dermal fillers | Medical device, implant | Reduction of Erythema in aesthetics injections |  |  |  | Seeking strategic partner | |
Chlorhexidine substitute mouthwash | Cosmetic product, oral | Malodor |  |  |  | Seeking strategic partner | |
Scar tape | Medical device | Prevention of HAIs, wound care |  |  | Seeking strategic partner | ||
A range of coated silicon-based medical devices | Medical device | Prevention of HAIs |  | Seeking strategic partner | |||
Wound irrigation | Medical device | Prevention of HAIs |  | Seeking strategic partner |
Contact us
Lets Get in Touch!
- info@n8medical.com
- N8 Medical, LLC1090 Center DrivePark City, UT 84098
mynewform
Basic contact form
Contact us
Lets Get in Touch!
- info@n8medical.com
- N8 Medical, LLC1090 Center DrivePark City, UT 84098
mynewform
Basic contact form
N8 Medical, Inc. (N8 Medical) is a clinical-stage medical device company focused on commercializing medical devices that incorporate a novel class of active compounds called ceragenins.The subsidiaries for N8 Medical Inc are N8 Medical, LLC for Medical Device Development and Kinnear Pharmaceuticals, LLC for drug development.
Our Company
N8 Medical, Inc. (N8 Medical) is a clinical-stage medical device company focused on commercializing medical devices that incorporate a novel class of active compounds called ceragenins.The subsidiaries for N8 Medical Inc are N8 Medical, LLC for Medical Device Development and Kinnear Pharmaceuticals, LLC for drug development.
